| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1029384070 |
| P356 | DOI | 10.2165/00024677-200403020-00005 |
| P698 | PubMed publication ID | 15743106 |
| P2093 | author name string | Marius J van der Mooren | |
| Tatjana E Vogelvang | |||
| Velja Mijatovic | |||
| P2860 | cites work | Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study | Q43788768 |
| A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study | Q44147950 | ||
| Menopause and risk of cardiovascular disease: the Framingham study. | Q50870268 | ||
| Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect | Q31825733 | ||
| Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial | Q31825740 | ||
| Hormone therapy to prevent disease and prolong life in postmenopausal women | Q34262585 | ||
| Tamoxifen reduces plasma homocysteine levels in healthy women | Q36292930 | ||
| Lipoprotein(a) and Atherosclerosis | Q37091985 | ||
| Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study | Q41732897 | ||
| Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study | Q43783590 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hormone Replacement Therapy | Q108667313 |
| P304 | page(s) | 105-115 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Treatments in Endocrinology: guiding your management of endocrine disorders | Q15749555 |
| P1476 | title | Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications | |
| P478 | volume | 3 |
| Q38561796 | Characterization of ligand type of estrogen receptor by MD simulation and mm-PBSA free energy analysis. |
| Q30659580 | Conjugated estrogens for the treatment of menopausal symptoms: a review of safety data |
| Q36885708 | Effects of tibolone on the breast of postmenopausal women |
| Q36383775 | Emerging selective estrogen receptor modulators: special focus on effects on coronary heart disease in postmenopausal women |
| Q38077503 | Evolution of the tissue selective estrogen complex (TSEC). |
| Q43715217 | Global profiling of TSEC proliferative potential by the use of a reporter mouse for proliferation. |
| Q36541698 | Sacral insufficiency fractures: current concepts of management |
| Q35602242 | The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial |
Search more.